The Aroon Indicator for JRSS entered a downward trend on December 13, 2024. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 143 similar instances where the Aroon Indicator formed such a pattern. In of the 143 cases the stock moved lower. This puts the odds of a downward move at .
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where JRSS's RSI Indicator exited the oversold zone, of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Momentum Indicator moved above the 0 level on November 29, 2024. You may want to consider a long position or call options on JRSS as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for JRSS just turned positive on December 04, 2024. Looking at past instances where JRSS's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. JRSS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: JRSS's P/B Ratio (33.743) is very high in comparison to the industry average of (4.577). P/E Ratio (0.357) is within average values for comparable stocks, (71.885). JRSS's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.595). JRSS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.026). P/S Ratio (24.592) is also within normal values, averaging (21.067).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. JRSS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
Industry MedicalNursingServices
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
HYXF | 46.00 | -0.53 | -1.13% |
iShares ESG Advanced Hi Yld Corp Bd ETF | |||
XDAP | 35.24 | -0.47 | -1.31% |
Innovator US Equity Acltd ETF™ April | |||
EDIV | 34.81 | -0.59 | -1.67% |
SPDR® S&P Emerging Markets Dividend ETF | |||
DEEF | 28.33 | -0.65 | -2.24% |
Xtrackers FTSE Develop ex US Mulfact ETF | |||
GSIE | 33.42 | -0.86 | -2.51% |
Goldman Sachs ActiveBeta® Intl Eq ETF |
A.I.dvisor tells us that JRSS and GBCS have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JRSS and GBCS's prices will move in lockstep.
Ticker / NAME | Correlation To JRSS | 1D Price Change % | ||
---|---|---|---|---|
JRSS | 100% | -10.59% | ||
GBCS - JRSS | 21% Poorly correlated | N/A | ||
SNDA - JRSS | 20% Poorly correlated | -5.22% | ||
LTGHY - JRSS | 3% Poorly correlated | -5.90% | ||
NVLPF - JRSS | 3% Poorly correlated | N/A | ||
ORPEF - JRSS | 0% Poorly correlated | N/A | ||
More |